In the last years, major progress occurred in heart failure (HF) management. Quadruple
therapy is now mandatory for all the patients with HF with reduced ejection fraction. Whilst …

In patients with heart failure, the beneficial effects of drug and device therapies counteract to
some extent ongoing cardiac damage. According to the net balance between these two …

Objectives The aim of this study is to examine the prognostic value of T1 mapping and the
extracellular volume (ECV) fraction in patients with dilated cardiomyopathy (DCM) …

Background Dilated cardiomyopathy (DCM) is a final common manifestation of
heterogenous etiologies. Adverse outcomes highlight the need for disease stratification …

Abstract Background Cine Displacement Encoding with Stimulated Echoes (DENSE)
facilitates the quantification of myocardial deformation, by encoding tissue displacements in …

Aims To characterize the phenotype, clinical outcomes and rate of disease progression in
patients with early‐stage non‐ischaemic cardiomyopathy (early‐NICM). Methods and results …

Dilated cardiomyopathy (DCM) is a leading cause of heart failure and life-threatening
ventricular arrhythmias (LTVA). Work-up and risk stratification of DCM is clinically …

Abstract Purpose of Review Cardiac magnetic resonance-feature-tracking (CMR-FT)-based
deformation analyses are key tools of cardiovascular imaging and applications in heart …

Aims To characterize adverse ventricular remodelling after withdrawing therapy in recovered
dilated cardiomyopathy (DCM). Methods and results TRED‐HF was a randomized controlled …

Aims Left ventricular reverse remodelling (LVRR) is a well‐established predictor of a good
prognosis in patients with dilated cardiomyopathy (DCM). The prediction of LVRR is …